Research Paper Volume 15, Issue 19 pp 10705—10731
Targeting circular RNA-Glra2 alleviates retinal neurodegeneration induced by ocular hypertension
Figure 4. cGlra2 is shown as a potential biomarker for glaucoma. (A) AH samples were collected from glaucoma patients (n = 20) and cataract patients (n = 20). qPCR assays were conducted to detect the levels of cGlra2 expression. The significant difference was determined by Student’s t-test. (B) Receiver operating characteristic (ROC) analysis and AUC calculation was conducted to evaluate the diagnostic value of cGlra2.